about
Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation.Structure-Function Correlation of Aminated Poly(α)glutamate as siRNA Nanocarriers.Administration, distribution, metabolism and elimination of polymer therapeutics.Nano-sized polymers and liposomes designed to deliver combination therapy for cancer.Interfering cancer with polymeric siRNA nanomedicines.Overcoming obstacles in microRNA delivery towards improved cancer therapy.Tagging the Untaggable: A Difluoroalkyl-Sulfinate Ketone-Based Reagent for Direct C-H Functionalization of Bioactive Heteroarenes.Inhibition of Gene Expression and Cancer Cell Migration by CD44v3/6-Targeted Polyion Complexes.A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.Novel pullulan bioconjugate for selective breast cancer bone metastases treatment.Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives.Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation.Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.HPMA copolymer-phospholipase C and dextrin-phospholipase A2 as model triggers for polymer enzyme liposome therapy (PELT).Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers.Nanoscale-Based Delivery of RNAi for Cancer TherapyStructure–Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer ImmunotherapyLight emission enhancement by supramolecular complexation of chemiluminescence probes designed for bioimagingA novel soluble supramolecular system for sustained rh-GH deliveryDirect Real-Time Monitoring of Prodrug Activation by ChemiluminescenceImage-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor marginsImmunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsPersistent Chemiluminescent Glow of Phenoxy-dioxetane Luminophore Enables Unique CRET-Based Detection of Proteases
P50
Q34473856-D7D7B151-1407-4534-AF5E-45666A400B2FQ36067633-9EA7B83F-C299-430D-B05B-648CDD85F3C5Q37979626-B91A5762-9FF6-4B37-88A2-D9102D277B79Q38111035-F0DBBB16-3CC4-46AE-9C5C-D6BC58AC0734Q38203902-B1D4FE08-39F9-4E38-8212-745740AC4811Q38382967-048E9D5E-F35D-48F2-9E3B-CD86BE366643Q38753690-FF4B3C72-7D8B-40F5-B2C8-2BE08A7F9F25Q38786562-A77F3A28-A405-4242-8C92-313E1F2405D2Q38887720-A3AB3906-A109-4E93-B1BF-35ED1B85B284Q38917437-8619064B-B495-4CFA-884E-08C4ADCEB85CQ39582137-7B9DADF3-584A-40E9-AC69-CE89325A751BQ39645639-BE044359-3404-4E71-B40B-128D151B8B8EQ42379504-BE62020D-43AA-4670-895C-217EFDC08501Q47946155-D17E1D63-5295-4E8A-B68B-366730D40969Q48546194-BE91C0F3-2446-4DC8-AFB5-6DF5383D0511Q49894294-CB748858-7B16-4D5B-9EA8-3B5139A1654FQ50064112-23C5B680-77A6-4055-9B0A-318C7F4C7A21Q50879676-B38B9B49-D45E-479A-A55F-8433F7C80E66Q57617335-0C16C77F-38FF-4CA1-BBB0-3CFED2D7BC14Q57617342-C24F8CE7-681F-4BCE-8593-048D8EF7A949Q59134491-78B49F2B-D45E-422E-9359-BE96EA71AFF5Q64274147-7754F510-F057-4330-AF28-22BB0C02C18BQ85258092-092A25AB-03A8-41CA-A6C4-542EB20875E9Q88770881-45899F2D-1085-4BA7-B024-E76CD5A3F917Q90352890-4C32A4A0-B27A-4D6B-A51B-11336522EFBEQ92432857-D07CD5A9-03B0-4B49-AEE6-69028988E01EQ93180600-768465B2-697A-4E4B-B005-140C309A6B45
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Scomparin
@ast
Anna Scomparin
@en
Anna Scomparin
@es
Anna Scomparin
@nl
type
label
Anna Scomparin
@ast
Anna Scomparin
@en
Anna Scomparin
@es
Anna Scomparin
@nl
prefLabel
Anna Scomparin
@ast
Anna Scomparin
@en
Anna Scomparin
@es
Anna Scomparin
@nl
P108
P106
P1153
23987897800
P21
P31
P496
0000-0003-4751-620X